Item 2.02. Results of Operations and Financial Condition
On November 15, 2022, The Oncology Institute, Inc. (the “Company”) issued a
slide presentation which includes the Company’s financial results for the three
and nine months ended September 30, 2022 and certain other financial
information. A copy of the presentation is furnished hereto as Exhibit 99.1,
which are incorporated by reference herein.
Item 7.01. Regulation FD Disclosure
On November 15, 2022, in conjunction with the slide presentation of its
financial results, the Company provided updates regarding the Company’s business
and guidance for the year ending December 31, 2022. The information provided
above in “Item 2.02 – Results of Operations and Financial Condition” of this
Current Report on Form 8-K (“Current Report”) is incorporated by reference into
this Item 7.01.
The information contained in Items 2.02 and 7.01 of this Current Report and
Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of such section.
Item 9.01 – Financial Statements and Exhibits
(d) The following exhibits are being filed herewith:
Exhibit No. Description 99.1 Slide presentation issued by The Oncology Institute, Inc. on November 15, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses